Infectious Disease
RSSArticles
-
Bioterrorism Watch: CDC gets plenty of advice for action
-
Bioterrorism Watch: Side effects undermine anthrax drug adherence
-
Bioterrorism Watch: Anthrax aftermath: Adverse drug reactions, vaccine controversy undercut CDC extended treatment offer
-
Bioterrorism Watch: Side effects undermine anthrax drug adherence
-
Bioterrorism Watch: Anthrax aftermath: Adverse drug reactions, vaccine controversy undercut CDC extended treatment offer
-
Bioterrorism Watch: Side effects undermine anthrax drug adherence
-
Bioterrorism Watch: Anthrax aftermath - Adverse drug reactions, vaccine controversy undercut CDC extended treatment offer
-
Bioterrorism Watch: Building a bridge over the abyss - Will bioterrorism help bring disjointed health system together?
-
Pertussis on the Rise — Atypical Infections Increasingly Common
-
Bioterrorism Watch: Was anthrax mailer a bioweapons researcher?